期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 151, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113126
关键词
Rheumatoid arthritis; Conventional drugs; RNA therapy; Phosphate-based treatments; Cannabinoid-based drugs
资金
- UM6P/OCP [OCP AS:99]
Rheumatoid arthritis is a chronic autoimmune disorder that affects the joints and can cause deformity and disability. Recent advancements in understanding the disease, early diagnosis, and new treatment options have been significant. Although non-steroidal antiinflammatory drugs, corticosteroids, and disease-modifying antirheumatic drugs are commonly used, not all patients respond well to them, highlighting the need for new solutions to improve outcomes.
Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic autoimmune disorder affects the lining of synovial joints in about 0.5% of people and may induce severe joints deformity and disability. RA impacts health life of people from all sexes and ages with more prevalence in elderly and women people. Significant improvement has been noted in the last two decades revealing the mechanisms of the development of RA, the improvement of the early diagnosis and the development of new treatment options. Non-steroidal antiinflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) remain the most known treatments used against RA. However, not all patients respond well to these drugs and therefore, new solutions are of immense need to improve the disease outcomes. In the present review, we discuss and highlight the recent findings concerning the different classes of RA therapies including the conventional and modern drug therapies, as well as the recent emerging options including the phyto-cannabinoid and cell- and RNA-based therapies. A better understanding of their mechanisms and pathways might help find a specific target against inflammation, cartilage damage, and reduce side effects in arthritis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据